Fredrik Scherstén
1 – 24 of 24
- show: 50
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
Clinical impact of intraprocedural stent thrombosis during percutaneous coronary intervention in patients treated with potent p2y12 inhibitors -A validate-swedeheart substudy
(
- Contribution to journal › Article
-
Mark
Characteristics and outcomes in patients with atrial fibrillation and acute coronary syndrome treated with ticagrelor and novel oral anticoagulants
(
- Contribution to journal › Article
- 2020
-
Mark
Incidence and outcome of myocardial infarction treated with percutaneous coronary intervention during COVID-19 pandemic
(
- Contribution to journal › Article
- 2019
-
Mark
Percutaneous haemodynamic and renal support in patients presenting with decompensated heart failure : A multi-centre efficacy study using the Reitan Catheter Pump (RCP)
(
- Contribution to journal › Article
-
Mark
Radial versus femoral access in patients with acute coronary syndrome undergoing invasive management : A prespecified subgroup analysis from VALIDATE-SWEDEHEART
(
- Contribution to journal › Article
-
Mark
Bivalirudin versus heparin monotherapy in non-ST-segment elevation myocardial infarction
(
- Contribution to journal › Article
- 2018
-
Mark
Tailored nurse-led cardiac rehabilitation after myocardial infarction results in better risk factor control at one year compared to traditional care : A retrospective observational study
(
- Contribution to journal › Article
-
Mark
Blood lactate is a predictor of short-term mortality in patients with myocardial infarction complicated by heart failure but without cardiogenic shock
(
- Contribution to journal › Article
- 2017
-
Mark
Cangrelor in combination with ticagrelor provides consistent and potent P2Y12-inhibition during and after primary percutaneous coronary intervention in real-world patients with ST-segment-elevation myocardial infarction
(
- Contribution to journal › Article
-
Mark
Bivalirudin versus heparin monotherapy in myocardial infarction
(
- Contribution to journal › Article
- 2016
-
Mark
Bivalirudin versus heparin in non-ST and ST-segment elevation myocardial infarction - A registry-based randomized clinical trial in the SWEDEHEART registry (the VALIDATE-SWEDEHEART trial)
(
- Contribution to journal › Article
-
Mark
Outcome after percutaneous coronary intervention for different indications : Long-term results from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR)
(
- Contribution to journal › Article
- 2015
-
Mark
Concomitant use of warfarin and ticagrelor as an alternative to triple antithrombotic therapy after an acute coronary syndrome.
(
- Contribution to journal › Article
- 2014
-
Mark
A pharmacodynamic comparison of 5 anti-platelet protocols in patients with ST-elevation myocardial infarction undergoing primary PCI.
(
- Contribution to journal › Article
-
Mark
Delay From First Medical Contact to Primary PCI and All-Cause Mortality: A Nationwide Study of Patients With ST-Elevation Myocardial Infarction.
(
- Contribution to journal › Article
- 2012
-
Mark
Long-term safety and efficacy of drug-eluting and bare metal stents in saphenous vein grafts
(
- Contribution to journal › Article
-
Mark
Triple antithrombotic therapy following an acute coronary syndrome: prevalence, outcomes and prognostic utility of the HAS-BLED score.
(
- Contribution to journal › Article
- 2011
-
Mark
Effect of upstream clopidogrel treatment in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
(
- Contribution to journal › Article
- 2010
-
Mark
Effect of upstream clopidogrel treatment in patients with ST-elevation myocardial infarction undergoing primary PCI
(
- Contribution to journal › Published meeting abstract
-
Mark
Safety and efficacy of drug-eluting vs. bare metal stents in patients with diabetes mellitus: long-term follow-up in the Swedish Coronary Angiography and Angioplasty Registry (SCAAR)
(
- Contribution to journal › Article
-
Mark
Prognostic effects of pre-hospital and in-hospital therapeutic interventions on 30-days mortality in patients with cardiogenic shock
(
- Contribution to journal › Published meeting abstract
-
Mark
Internationell och nationell konsensus om bästa vård efter hävt hjärtstopp. Många patienter blir helt återställda.
(
- Contribution to journal › Scientific review
- 2009
-
Mark
Stent Thrombosis in Sweden A Report From the Swedish Coronary Angiography and Angioplasty Registry
(
- Contribution to journal › Article
- 2005
-
Mark
Successful resuscitation with mechanical CPR, therapeutic hypothermia and coronary intervention during manual CPR after out-of-hospital cardiac arrest
(
- Contribution to journal › Article